Penumbra (PEN) Operating Income (2014 - 2026)
Penumbra (PEN) posted quarterly Operating Income of $41.0 million for Q2 2026, up 0.52% year-over-year from $40.8 million in Q2 2025, and up 7.34% quarter-over-quarter from $38.2 million in Q1 2026.
Penumbra (PEN) Operating Income (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Operating Income for 13 consecutive years, with $41.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Operating Income rose 0.52% year-over-year to $41.0 million; the TTM figure through Jun 2026 stood at $187.3 million (up 17.59% YoY), while the FY2025 annual figure was $189.2 million, up 1939.54% from the prior year.
- Operating Income climbed to $41.0 million in Q2 2026 per PEN's latest filing, from $38.2 million in the prior quarter.
- Across five years, Operating Income topped out at $59.2 million in Q4 2025 and bottomed at -$81.0 million in Q2 2024.
- Historically, Operating Income has averaged $19.9 million across 5 years, with a median of $26.5 million in 2023.
- Annual changes were most pronounced in 2023 — Operating Income soared 12969.78% — and 2024, when it sank 552.57%.
- Penumbra's Operating Income stood at $4.8 million in 2022, then soared by 624.79% to $35.0 million in 2023, then grew by 22.11% to $42.8 million in 2024, then surged by 38.48% to $59.2 million in 2025, then tumbled by 30.72% to $41.0 million in 2026.
- Business Quant data shows PEN's Operating Income at $41.0 million in Q2 2026, $38.2 million in Q1 2026, and $59.2 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 989.17 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Penumbra | 12.80 Bn | 12.14 Bn | 264.94 Mn | 41.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.04 Mn |
| Mar 31, 2026 | 38.23 Mn |
| Dec 31, 2025 | 59.23 Mn |
| Sep 30, 2025 | 48.84 Mn |
| Jun 30, 2025 | 40.83 Mn |
| Mar 31, 2025 | 40.35 Mn |
| Dec 31, 2024 | 42.78 Mn |
| Sep 30, 2024 | 35.36 Mn |
| Jun 30, 2024 | -80.96 Mn |
| Mar 31, 2024 | 12.10 Mn |
| Dec 31, 2023 | 35.03 Mn |
| Sep 30, 2023 | 12.63 Mn |
| Jun 30, 2023 | 17.89 Mn |
| Mar 31, 2023 | 8.01 Mn |
| Dec 31, 2022 | 4.83 Mn |
| Sep 30, 2022 | 5.43 Mn |
| Jun 30, 2022 | -139,000.00 |
| Mar 31, 2022 | -4.05 Mn |
| Dec 31, 2021 | -40.06 Mn |
| Sep 30, 2021 | 8.78 Mn |